All news articles
Wednesday 17 April 2019 Scotland
Breast Cancer Care and Breast Cancer Now responded to the Clinical Risk Assessment report on the clinical...
Wednesday 10 April 2019 Health information
NICE has provisionally rejected breast cancer drug ribociclib in combination with fulvestrant for use on the NHS in...
Simple test could predict response to anthracycline chemotherapy for patients with ‘triple negative’ breast cancer
Wednesday 10 April 2019 Our research
Researchers at Queen’s University Belfast have found a new biomarker which could...
Friday 5 April 2019 Scotland
A new report has highlighted inconsistencies in breast cancer care in NHS Tayside.
Tuesday 2 April 2019 Health information
NICE has today published draft guidance recommending breast cancer drug abemaciclib with fulvestrant for use...
Charity event thanks lifestyle coaches for their support in pioneering Scottish breast cancer risk trial
We held a charity event to thank 45 volunteer Lifestyle Coaches for their involvement in the ActWELL research...
Tuesday 19 March 2019 Latest research
According to new research, mortality rates from breast cancer are predicted to fall...
We respond to news that immunotherapy atezolizumab is to be made temporarily available to certain NHS breast cancer patients via early access scheme
Friday 15 March 2019 Health information
Atezolizumab (Tecentriq) is to be made available in the short term for certain NHS patients with metastatic ‘triple...
Thursday 14 March 2019 Health information
New monthly cancer waiting times figures have been released today by NHS England.
Genetic and molecular analysis of individual breast tumours could help predict the likelihood of a woman’s disease...